Approval · Notice of Compliance 2268 · 2001
HALOTESTIN: Notice of Compliance 2268
Issued June 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2268
- Date
- June 22, 2001
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Androgenic-anabolic steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOTESTIN | 00030902 | Cancelled Post Market |
Medicinal ingredients
- FLUOXYMESTERONE 5 MG per TAB